Allergic Diseases Through Precision Medicine

In the realm of immunology, the study of allergic diseases stands out due to their widespread impact and escalating prevalence globally. Historically, conditions such as atopic dermatitis, food allergy, allergic rhinitis, and allergic asthma have seen dramatic increases in incidence, potentially driven by factors including climate change. These allergic diseases originate early in life, where genetic and environmental factors interplay to shape the immune response.

This Research Topic aims to bridge the gap between traditional allergy treatments and cutting-edge precision medicine. The utilization of advanced systems biology tools has begun to elucidate the complex pathways between environmental exposures and cellular responses, paving the way for more targeted and effective interventions. Through precision medicine, we seek to enhance early detection, improve treatment options, and develop preventive strategies that are tailored to individual profiles.

To gather further insights into the nuanced field of allergy and precision medicine, we welcome articles addressing, but not limited to, the following themes:

•Climate Change Impact on Allergic Disease Prevalence: A Precision Medicine Approach.
•Precision Analysis of Host-Microbiome Interactions in Allergic Diseases.
•Application of Omics Technologies for Precision Medicine in Allergy.
•Precision Immunotherapy Advances in Allergic Diseases.
•Immunometabolic Pathways in Allergy: Precision Medicine Insights.
•Precision Medicine in Identifying Novel Endotypes and Molecular Mechanisms in Allergic Diseases.
•Precision Strategies for Early Detection of Allergic Diseases in High-Risk Individuals.
•Innovative Precision Medicine Modalities for Treatment and Prevention of Allergic Diseases.
•Drug Repurposing in Allergic Disease Management Through Precision Medicine.
•Biomarker-Driven Optimization of Precision Therapies in Allergic Diseases.

AB is a co-founder, equity holder, and director of the startup company Respiradigm Pty Ltd and subsidiary First Breath Health Pty Ltd that is related to this work. AB is the founder of the startup company INSiGENe Pty Ltd that is related to this work. The other Topic Editors report no competing interests related to this Research Topic.

Keywords: allergy, asthma, immunology, microbiome, personalized medicine, omics, systems biology

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.